Metformin Hydrochloride Market Report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry, by summing up the previous growth patterns, the growth drivers and the current and future trends.
Los Angeles, CA -- (SBWIRE) -- 02/14/2019 -- Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes.
With the accelerated pace of life and increasing aging population, global morbidity and mortality of diabetes disease increased year by year. Metformin hydrochloride is an efficient solution to the diseases. With increasing downstream demand, global Metformin hydrochloride API production also increased from 20267 MT in 2011 to 30374 MT in 2015, with CAGR of 10.64%. Raw materials of Metformin hydrochloride are mainly hydrochloric acid and dimethylamine etc. The raw materials are common and the price is relative steady in the past few years. For the API product, there are many manufacturers in China, such as Shouguang Fukang Pharmaceutical, CR Double-Crane, Keyuan Pharmaceutical and Shijiazhuang Polee Pharmaceutical.
Shouguang Fukang Pharmaceutical is also a global leader in this industry. In 2015, Metformin hydrochloride production value of Shouguang Fukang Pharmaceutical was about 18.0 Million USD. The global Metformin Hydrochloride market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Metformin Hydrochloride volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metformin Hydrochloride market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
Get PDF Version of this Report @ https://www.qyresearch.com/sample-form/form/964345/global-metformin-hydrochloride-market
The following manufacturers are covered:
Shouguang Fukang Pharmaceutical
Shijiazhuang Polee Pharmaceutical
Segment by Regions
Segment by Type
Get Full Comprehensive Industry Insights @ https://www.qyresearch.com/settlement/pre/8da164eb178bd3370dbe903bcf8ea439,0,1,Global%20Metformin%20Hydrochloride%20Market%20Research%20and%20Forecast%202019
Segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.